Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial) / Quang A. Le en The Journal of Clinical Psychiatry, Año 2014 - Vol.75 - No.3 (Marzo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2014 - Vol.75 - No.3 (Marzo) . - pp. 222-230 Título : Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial) : a doubly randomized preference trial Tipo de documento: texto impreso Autores: Quang A. Le, Autor ; Jason N Doctor, Autor ; Lori A. Zoellner, Autor Fecha de publicación: 2022 Artículo en la página: pp. 222-230 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Servicios de salud, Terapia Implosiva, Calidad de vida, Inhibidores de la captación de serotonina, Sertralina, Trastornos por estrés postraumático. Resumen: Cost-effectiveness of treatment for posttraumatic stress disorder (PTSD) may depend on type of treatment (eg, pharmacotherapy vs psychotherapy) and patient choice of treatment. We examined the cost-effectiveness of treatment with prolonged exposure therapy versus pharmacotherapy with sertraline, overall treatment preference, preference for choosing prolonged exposure therapy, and preference for choosing pharmacotherapy with sertraline from the US societal perspective. Link: ./index.php?lvl=notice_display&id=27807 [artículo] Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial) : a doubly randomized preference trial [texto impreso] / Quang A. Le, Autor ; Jason N Doctor, Autor ; Lori A. Zoellner, Autor . - 2022 . - pp. 222-230. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2014 - Vol.75 - No.3 (Marzo) . - pp. 222-230 Etiquetas: Servicios de salud, Terapia Implosiva, Calidad de vida, Inhibidores de la captación de serotonina, Sertralina, Trastornos por estrés postraumático. Resumen: Cost-effectiveness of treatment for posttraumatic stress disorder (PTSD) may depend on type of treatment (eg, pharmacotherapy vs psychotherapy) and patient choice of treatment. We examined the cost-effectiveness of treatment with prolonged exposure therapy versus pharmacotherapy with sertraline, overall treatment preference, preference for choosing prolonged exposure therapy, and preference for choosing pharmacotherapy with sertraline from the US societal perspective. Link: ./index.php?lvl=notice_display&id=27807

---

1 (1 - 1 / 1) Por página: 25 50 100 200